Clinical Trial Update: Evaluation of Oxaliplatin and Gemcitabine in Patients With Metastatic Bladder Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating oxaliplatin and gemcitabine in metastatic bladder cancer (carcinoma, transitional cell); study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Carcinoma Transitional Cell

Drugs mentioned

• Gemcitabine (Gemcitabine)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: University of California, Irvine | Conditions: Carcinoma, Transitional Cell | Phase 2 | Status: TERMINATED | Results posted: 2020-01-02